Atlas Trials

Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)

Clinical trial NCT04627402 · UNKNOWN

Trial details

NCT number
NCT04627402
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Macular Edema
Start date
2020-11-12
Primary completion
2021-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.